Clinical Trials in Chicago

Showing 2021-2040 of 9,860 trials

Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis

NCT05186805

This is an open-label, multicenter study to evaluate the systemic exposure and safety of topical tapinarof cream, 1% under conditions of maximal use in pediatric subjects with atopic dermatitis

Atopic Dermatitis

Organon and Co36 participantsStarted Nov 2021

Thousand Oaks, California, United States • Centennial, Colorado, United States • Coral Gables, Florida, United States +7 more locations

RECRUITINGPhase 1/22.2 miles

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

NCT04486352

This is a Phase IB/II multi-cohort study designed to evaluate the efficacy and safety of targeted agents with or without cancer immune checkpoint therapy with atezolizumab in participant with recurrent and/or persistent endometrial cancer. The main protocol provides a platform for genomic screening with homogeneous basic eligibility criteria in order to direct study participants into biomarker-matched study cohorts consisting of testing targeted agents.

Endometrial Cancer

Alliance Foundation Trials, LLC.148 participantsStarted Oct 2021

Duarte, California, United States • San Francisco, California, United States • Washington D.C., District of Columbia, United States +18 more locations

Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

Find Trials by Condition in Chicago

A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy

A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease

A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat

Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial

Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults

A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Adenocarcinoma (AC)

A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee

SHAPE for ICP Assessment

A Multicenter Pragmatic Implementation Study of ECG-AI-Based Clinical Decision Support Software to Identify Low LVEF

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

A Clinical Trial to Evaluate the Safety and Immunogenicity of Glycan-trimmed HIV-1 Nanoparticle Vaccine (UVAX-1107), Followed by Homologous or Wild-type HIV-1 Nanoparticle Vaccine (UVAX-1197) Boost, Each Adjuvanted With 3M-052-AF + Alum in Adult Participants Without HIV

GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)

A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2